Patents by Inventor Benjamin Salisbury

Benjamin Salisbury has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150307941
    Abstract: The invention is based, at least in part, on the observation that the presence of particular biomarkers, e.g., particular mutations in any of the KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2 genes as identified in Tables 1-5 (and, in particular, those identified with an asterisk), is associated with Long QT Syndrome (LQTS).
    Type: Application
    Filed: January 10, 2014
    Publication date: October 29, 2015
    Inventors: Benjamin Salisbury, Carole L. Harris-Kerr
  • Patent number: 8658358
    Abstract: The invention is based, at least in part, on the observation that the presence of particular biomarkers, e.g., particular mutations in any of the KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2 genes as identified in Tables 1-5 (and, in particular, those identified with an asterisk), is associated with Long QT Syndrome (LQTS).
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: February 25, 2014
    Assignee: Transgenomic, Inc.
    Inventors: Benjamin Salisbury, Carole L. Harris-Kerr
  • Publication number: 20090233942
    Abstract: Markers of the ACE, ATP5C3, BCL2L1, CYP2C9, DRD3, FOS, DTNBP1, GABRG3, GRIA4, LAMA4, MAPK1, NPY1R, OPRD1, OPRM1, PER3, PLCB1, PSMD1, ABI1, LOC402382, and NCALD genes, and their association with response to antidepressants are disclosed. Compositions and methods for detecting and using these markers in a variety of clinical applications are disclosed.
    Type: Application
    Filed: March 13, 2008
    Publication date: September 17, 2009
    Inventors: Maria Athanasiou, Kerri Holick, Carol Reed, Benjamin Salisbury, Alessandro Serretti, Wei Zou